Finn Stockinger
Equity Analyst & Investor, Technology Research
Everspin's 38.6% surge to $18.28 after its Q1 beat has likely pulled forward much of the near-term upside: at about $425M, or 7x trailing sales, it already prices in much of 2026-2027 growth. Product sales grew 28% to $14.1M and a $40M defense contract bridges about $16M a year, but reaching $25-$30 needs quarterly revenue above $20M, hinging on July 2026 STT-MRAM qualification and a Microchip ramp with recurring orders not due until 2H 2027. Litigation costs weigh on GAAP income. x.com
Everspin's MRAM technology is compelling, but the runway to real revenue is too long. Revenue has been stuck around $14-15 million a quarter, and its 238 design wins in 2025 typically take 18-24 months to reach mass production. The April 8 Microchip agreement is a breakthrough, but first Toggle MRAM products arrive around late 2027 and higher-margin STT-MRAM closer to 2028. Doubling revenue by 2029 is achievable, but that pace is not enough to justify owning the stock now. x.com x.com
Everspin's execution does not match its monopoly: revenue growth has been inconsistent and margins all over the place, so results look worse than its positioning warrants. It is the world's only at-scale maker of Toggle MRAM, radiation-immune memory the US military uses in missiles, submarines and aerospace. Its new $40M Department of War contract requires it to hand over its process technology if it ever stops making MRAM, and a Microchip partnership adds domestic production in Oregon. x.com
Microchip's long-term foundry deal with Everspin adds quality option value and strengthens its standing as a US specialty manufacturer, though the stock still hinges on inventory, utilization, margins and debt. Microchip will make Everspin's MRAM and TMR sensor wafers at its Oregon Fab 4 for at least ten years, putting idle capacity to work as an ITAR-ready onshore source. First shipments target late 2027 and volumes are small, so the near-term earnings impact is limited. x.com x.com x.com x.com … Show more
Everspin Technologies looks cheap against its sales, trading at 7x sales and 5x next year's when chipmakers usually get 6x. At 6x next year's sales, give or take 12%, fair value is $20.03-$25.49, versus $18.71 now. This is a levels-only read off reported earnings and revenue estimates, with no fundamental work. x.com
Everspin now looks somewhat overvalued, because its monopoly in discrete MRAM does not justify current valuations. x.com
Everspin is among the weak small caps that would be hit hardest if multiples compress for AI infrastructure suppliers, and it does not deserve a $600M valuation. x.com
Everspin Technologies is a high-risk MRAM pure play that could multiply if MRAM scales. Microchip's onshore MRAM foundry deal secures a second source, and expanded production feeds directly into revenue, with defense, space and AI-edge memory demand as beneficiaries. The real test is 2027-2029, when mass production, customer growth and revenue must show up; today expectations exceed results. Risks include a small, volatile company, customer concentration, an early market and production delays. … Show more
Everspin's MRAM rally makes little sense, as the market is not that large and there is no MRAM monopoly. Absent an unknown breakthrough using MTJs for AI, there is no reason for the bid, and the space angle, raised by @ryandonovan23, fails because data centers will never be in space. x.com x.com x.com
Everspin's MRAM story already looks priced in on expectations. It needs a clearer catalyst showing visibility into space-computing infrastructure before the shares can move higher. x.com
Everspin is the only US-domiciled, US-manufactured MRAM maker, and its non-volatile, fast, radiation-hardened memory works where flash and DRAM cannot, making it a Pentagon supplier with no alternative. Its 10-year Microchip deal for a copy-exact line in Oregon doubles domestic capacity from H2 2027. Its UNISYST NOR flash replacement targets 5-10% of a $3 billion market, with production in 2027. It had 238 design wins in 2025, up 34%, with 52.7% gross margins and no debt. x.com x.com x.com x.com … Show more
Microchip's new quantum-safe cybersecurity chips, launched in late April, could bring major deals as US CNSA 2.0 rules require quantum-safe security in new defense and national-security systems from January 2027. Microchip is deeply embedded there; its CEO says it is in every offensive and defensive US weapon. Its 100k+ customers in industrial, data center, auto and communications will likely adopt too. No deals are announced yet, but record buy volume makes it a top stock to accumulate. x.com … Show more
